Search - tctmd.com

Displaying 1 - 20 of 63

Sort: Relevancy | Date

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

News Daily News

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

January 08, 2026

Presentation TCT 2025

TCT 1922: Successful Endovascular Treatment for MTB Infection Related Mycotic Subclavian Artery Aneurysm After Intravesical BCG Treatment for Bladder Malignancy

Presenter: Jae Young Jeung

October 27, 2025

Presentation TCT 2025

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

Presenter: Hasnan M. Ijaz

October 26, 2025

Get More Women to Cardiac Rehab, AHA Asserts

News Daily News

Get More Women to Cardiac Rehab, AHA Asserts

October 22, 2025

TCT 838: Clinical Futility in Patients With Active Malignancy Undergoing Trans-Catheter Aortic Valve Replacement After Multidisciplinary Heart Team Decision

Presentation TCT 2024

TCT 838: Clinical Futility in Patients With Active Malignancy Undergoing Trans-Catheter Aortic Valve Replacement After Multidisciplinary Heart Team Decision

Presenter: Enrico Romagnoli

October 29, 2024

TCT 1256: Malignancy-Induced Hypercoagulability: A Precipitating Factor in Acute Stent Thrombosis

Presentation TCT 2024

TCT 1256: Malignancy-Induced Hypercoagulability: A Precipitating Factor in Acute Stent Thrombosis

Presenter: Michael Sabina

October 28, 2024

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

May 17, 2024

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

January 02, 2024

High Troponin Signals Increased Mortality Risk in Broad Hospital Cohort

News Daily News

High Troponin Signals Increased Mortality Risk in Broad Hospital Cohort

August 10, 2023

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

News Daily News

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

July 19, 2023

Assessing Age-Specific Difference in Clinical Adverse Outcomes After Transcatheter Aortic Valve Replacement in Patients With Hematologic Malignancy

Presentation TVT 2023

Assessing Age-Specific Difference in Clinical Adverse Outcomes After Transcatheter Aortic Valve Replacement in Patients With Hematologic Malignancy

Presenter: Ayobami Olafimihan

June 08, 2023

Incidental Cancer on a Pre-TAVI Workup Tied to Poorer Outcomes

News Daily News

Incidental Cancer on a Pre-TAVI Workup Tied to Poorer Outcomes

April 06, 2023

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

News Conference News AHA 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

November 06, 2022

Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis

News Daily News

Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis

December 16, 2021

DNRs Muddy Waters in Acute MI Care as Palliative Services Fall Short

News Daily News

DNRs Muddy Waters in Acute MI Care as Palliative Services Fall Short

Yael L. Maxwell

October 27, 2021

COVID-19: TCTMD’s Dispatch for October Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 4

October 25, 2021

For Cardiac Tumors, CMR Proves Powerful for Predicting Mortality

News Daily News

For Cardiac Tumors, CMR Proves Powerful for Predicting Mortality

Yael L. Maxwell

September 29, 2021

No Paclitaxel Death Signal in VA Data Out to 3 Years

News Daily News

No Paclitaxel Death Signal in VA Data Out to 3 Years

February 11, 2021

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.